Thermo Fisher Scientific (NYSE:TMO) is expanding its presence in proteomic biomarker analytics and immuno-oncology ...

Thermo Fisher Scientific, already a big player in providing services to the biopharmaceutical industry, is adding to its technology capabilities with the $9 billion acquisition of clinical trial ...

What if you'd invested in Thermo Fisher Scientific (TMO) ten years ago? It may not have been easy to hold on to TMO for all ...

Thermo Fisher Scientific stock is at EUR 613.20 in weekend trading on October 18, 2026. Results are due October 21, 2026. On ...

Thermo Fisher Scientific remains overvalued despite strong Q2/26 results and a 30% stock rally since the last review. I rate the TMO stock a Hold. Read my analysis now.

On CNBC’s “Halftime Report Final Trades,” Stephen Weiss, chief investment officer and managing partner of Short Hills Capital ...

Detailed price information for Thermo Fisher Scientific (TMO-N) from The Globe and Mail including charting and trades.

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

Thermo Fisher Scientific stock trades pre-market at EUR 621.70 at 7:42 a.m. CEST at Lang & Schwarz on October 16, 2026. The ...

Thermo Fisher just set a 52-week high at $696.49, roughly 56% above its March low. The $257.6 billion life-science tools name ...

Thermo Fisher Scientific, the world leader in serving science, is expanding its drug development, manufacturing, and clinical capabilities to help pharmaceutical and biotechnology companies navigate ...